tradingkey.logo

Quest Diagnostics Inc

DGX

178.530USD

+1.849+1.05%
收盘 04/29, 16:00美东报价延迟15分钟
20.00B总市值
23.09市盈率 TTM

Quest Diagnostics Inc

178.530

+1.849+1.05%
关于 Quest Diagnostics Inc 公司
Quest Diagnostics Incorporated 是一家诊断信息服务提供商。该公司根据实验室检测结果提供诊断见解,使人们、医生和组织能够采取行动改善健康结果。该公司通过 DIS 部门运营,该部门为其主要客户渠道内的一系列客户提供诊断信息服务:医生、医院、患者和消费者。该公司通过全国性的实验室网络、患者服务中心、医生办公室的采血师和连接资源(包括呼叫中心和移动采血师、护士和其他健康和保健专业人员)提供广泛的临床检测渠道。该公司还专注于为生物制药公司和病理实验室提供人工智能 (AI) 和数字病理解决方案。该公司已在多个实验室和业务职能部门实施了人工智能、数字和自动化技术。
公司简介
公司代码DGX
公司名称Quest Diagnostics Inc
上市日期Dec 17, 1996
成立日期1996
CEOMr. James E. (Jim) Davis
员工数量45000
证券类型Ordinary Share
年结日Dec 17
公司地址500 Plaza Drive
城市SECAUCUS
上市交易所NYSE Consolidated
国家United States of America
邮编07094
电话19735202700
网址https://www.questdiagnostics.com/
公司代码DGX
上市日期Dec 17, 1996
成立日期1996
公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
72.49K
-1.40%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
44.41K
+4.88%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
39.12K
-12.25%
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
33.68K
+2.00%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
25.09K
--
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
16.87K
--
Mr. Karthik Kuppusamy
Mr. Karthik Kuppusamy
Senior Vice President - Clinical Solutions
Senior Vice President - Clinical Solutions
12.52K
-16.95%
Ms. Denise M. Morrison
Ms. Denise M. Morrison
Independent Director
Independent Director
10.65K
+0.69%
Ms. Tracey C. Doi
Ms. Tracey C. Doi
Independent Director
Independent Director
5.26K
+1.92%
Mr. Robert B. (Rob) Carter
Mr. Robert B. (Rob) Carter
Independent Director
Independent Director
1.48K
--
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
72.49K
-1.40%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
44.41K
+4.88%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
39.12K
-12.25%
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
33.68K
+2.00%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
25.09K
--
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
16.87K
--
收入明细
单位: USD更新时间: 4月6日 周日
单位: USD更新时间: 4月6日 周日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Routine clinical testing services
5.03B
51.00%
Gene-based and esoteric testing services
3.85B
39.00%
Anatomic pathology testing services
592.32M
6.00%
All other
296.16M
3.00%
COVID-19 testing services
98.72M
1.00%
地区USD
名称
营收
占比
United States
9.87B
100.00%
业务
地区
业务USD
名称
营收
占比
Routine clinical testing services
5.03B
51.00%
Gene-based and esoteric testing services
3.85B
39.00%
Anatomic pathology testing services
592.32M
6.00%
All other
296.16M
3.00%
COVID-19 testing services
98.72M
1.00%
股东统计
更新时间: 2月21日 周五
更新时间: 2月21日 周五
持股股东
股东类型
持股股东
股东统计
占比
The Vanguard Group, Inc.
12.46%
BlackRock Institutional Trust Company, N.A.
5.72%
T. Rowe Price Associates, Inc.
4.77%
State Street Global Advisors (US)
4.68%
Victory Capital Management Inc.
3.01%
Other
69.36%
持股股东
股东统计
占比
The Vanguard Group, Inc.
12.46%
BlackRock Institutional Trust Company, N.A.
5.72%
T. Rowe Price Associates, Inc.
4.77%
State Street Global Advisors (US)
4.68%
Victory Capital Management Inc.
3.01%
Other
69.36%
股东类型
股东统计
占比
Investment Advisor/Hedge Fund
43.26%
Investment Advisor
39.46%
Research Firm
3.59%
Hedge Fund
2.38%
Pension Fund
2.23%
Bank and Trust
1.51%
Sovereign Wealth Fund
1.20%
Individual Investor
0.44%
Insurance Company
0.10%
Other
5.83%
机构持股
更新时间: 1月20日 周一
更新时间: 1月20日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q1
1728
104.89M
94.51%
-2.04M
2024Q4
1799
104.71M
94.35%
-2.70M
2024Q3
1750
102.92M
92.46%
-3.55M
2024Q2
1759
102.88M
92.68%
-4.95M
2024Q1
1761
104.07M
93.75%
-1.69M
2023Q4
1784
101.50M
91.43%
-7.03M
2023Q3
1779
103.39M
92.29%
-7.25M
2023Q2
1792
104.49M
93.26%
-6.44M
2023Q1
1797
105.56M
94.19%
-4.32M
2022Q4
1821
104.62M
94.12%
-9.73M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
13.91M
12.54%
-8.04K
-0.06%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
6.38M
5.75%
-47.02K
-0.73%
Dec 31, 2024
T. Rowe Price Associates, Inc.
5.33M
4.8%
+1.63M
+44.23%
Dec 31, 2024
State Street Global Advisors (US)
5.22M
4.71%
-41.76K
-0.79%
Dec 31, 2024
Victory Capital Management Inc.
3.36M
3.03%
-104.37K
-3.01%
Dec 31, 2024
Geode Capital Management, L.L.C.
2.69M
2.42%
+73.37K
+2.80%
Dec 31, 2024
Davis Selected Advisers, L.P.
2.40M
2.16%
-1.84K
-0.08%
Dec 31, 2024
Grantham Mayo Van Otterloo & Co LLC
2.27M
2.04%
+26.21K
+1.17%
Dec 31, 2024
JP Morgan Asset Management
2.12M
1.91%
+986.50K
+87.23%
Dec 31, 2024
Dimensional Fund Advisors, L.P.
2.04M
1.84%
-5.16K
-0.25%
Dec 31, 2024
查看更多
持股ETF
更新时间: 4月6日 周日
更新时间: 4月6日 周日
机构名称
占比
Global X Telemedicine & Digital Health ETF
4.06%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
3.48%
iShares U.S. Healthcare Providers ETF
2.96%
Madison Dividend Value ETF
2.85%
Davis Select US Equity ETF
2.79%
Monarch Volume Factor Dividend Tree Index ETF
2.75%
First Trust Total US Market AlphaDEX ETF
2.29%
Invesco Bloomberg MVP Multi-Factor ETF
2.21%
Invesco Raymond James SB-1 Equity ETF
2.16%
SPDR S&P Health Care Services ETF
2.03%
查看更多
Global X Telemedicine & Digital Health ETF
占比4.06%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
占比3.48%
iShares U.S. Healthcare Providers ETF
占比2.96%
Madison Dividend Value ETF
占比2.85%
Davis Select US Equity ETF
占比2.79%
Monarch Volume Factor Dividend Tree Index ETF
占比2.75%
First Trust Total US Market AlphaDEX ETF
占比2.29%
Invesco Bloomberg MVP Multi-Factor ETF
占比2.21%
Invesco Raymond James SB-1 Equity ETF
占比2.16%
SPDR S&P Health Care Services ETF
占比2.03%
分红派息
近5年累计派现 1.56B 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Nov 12, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jan 29, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Jan 29, 2025
Jan 14, 2025
Aug 14, 2024
DGX.NB Final Cash Dividend of gross USD 0.75 paid on Oct 21, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Oct 21, 2024
Oct 04, 2024
May 15, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 22, 2024 going ex on Jul 08, 2024
Jul 08, 2024
Jul 22, 2024
Jul 08, 2024
Feb 01, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Apr 22, 2024 going ex on Apr 05, 2024
Apr 08, 2024
Apr 22, 2024
Apr 05, 2024
Nov 14, 2023
DGX.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 31, 2024 going ex on Jan 16, 2024
Jan 17, 2024
Jan 31, 2024
Jan 16, 2024
Aug 14, 2023
DGX.NB Final Cash Dividend of gross USD 0.71 paid on Oct 23, 2023 going ex on Oct 05, 2023 with reinvestment option
Oct 06, 2023
Oct 23, 2023
Oct 05, 2023
May 16, 2023
DGX.NB Interim Cash Dividend of gross USD 0.71 paid on Jul 25, 2023 going ex on Jul 10, 2023 with reinvestment option
Jul 11, 2023
Jul 25, 2023
Jul 10, 2023
Feb 02, 2023
DGX.NB Interim Cash Dividend of gross USD 0.71 paid on Apr 24, 2023 going ex on Apr 06, 2023 with reinvestment option
Apr 10, 2023
Apr 24, 2023
Apr 06, 2023
Nov 15, 2022
DGX.NB Interim Cash Dividend of gross USD 0.66 paid on Feb 01, 2023 going ex on Jan 17, 2023
Jan 18, 2023
Feb 01, 2023
Jan 17, 2023
Aug 10, 2022
DGX.NB Final Cash Dividend of gross USD 0.66 paid on Oct 19, 2022 going ex on Oct 03, 2022
Oct 04, 2022
Oct 19, 2022
Oct 03, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有